Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Apr 28, 2022 6:43pm
141 Views
Post# 34640587

RE:Is anyone one adding? Why or why not?

RE:Is anyone one adding? Why or why not?I cannot justify adding more.  I've been tempted a few times, but I already have way too much of my portfolio allocated to this one stock.  To-date, I am down $108K.  $28K of that is a realized loss I took last year for tax purposes and won't get back.  This year my unrealized loss has accelerated greatly as the stock continues to plummet.  I voted all my shares against the entire board.  This is largely on them.  With investor relations, trust issues, a seriously declining stock price, they should have taken more care in explaining the decision to back up on Europe, especially coming off that earnings call just days before.  Eliminate any and all trust issues by taking the time to explain it and reconcile back to the previous made remarks.  On the surface without context and the reading of tea leaves, it looks like a complete turnabout on the business strategy.  I've lost all confidence in the board, but am still holding out for a hail marry that they actually have found something valuable.  It would hurt me really bad, but I'm prepared to lose the entire rest of my investment.  At this point, I haven't ruled that out of the question.

BlitzBuuckeyeoh wrote: I am , still believe they see something with all the hiring. Great opportunity if you aren't in a hurry. 


<< Previous
Bullboard Posts
Next >>